Evidence map›Paper›PMID 33670028›Full record

ArticleViruses2021

Improving the Inhibitory Effect of Phages against

Bahareh Lashtoo Aghaee, Mohammadali Khan Mirzaei, Mohammad Yousef Alikhani, Ali Mojtahedi, Corinne F Maurice

Abstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Microbiotherapy: an emerging adjunct for burn wound healing.Frontiers in cellular and infection microbiology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Viruses · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Infectious medicine · 2023
    Review
  16. Enzyme Production and Inhibitory Potential ofAntibiotics (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Bacteriophage-Antibiotic Combination Therapy againstAntibiotics (Basel, Switzerland) · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bahareh Lashtoo AghaeeDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan 65178-38678, Iran.
Mohammadali Khan MirzaeiInstitute of Virology, Helmholtz Center Munich and Technical University of Munich, 85764 Neuherberg, Germany.ORCID 0000-0003-2801-4474
Mohammad Yousef AlikhaniDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan 65178-38678, Iran.
Ali MojtahediDepartment of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht 41938-33697, Iran.
Corinne F MauriceDepartment of Microbiology & Immunology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 0B1, Canada.

Funding

CIHR PJT-149098
6 · The paper itself

Abstract

Antibiotic resistance causes around 700,000 deaths a year worldwide. Without immediate action, we are fast approaching a post-antibiotic era in which common infections can result in death.

Indexed as

Anti-Bacterial AgentsBurnsHumansMicrobial Sensitivity TestsPhage TherapyPhylogenyPseudomonas aeruginosaPseudomonas InfectionsPseudomonas PhagesRiversSewageAnti-Bacterial AgentsSewageantibiotic resistancebacteriophagePseudomonas aeruginosa

Identifiers

PMID33670028
PMCPMC7926668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.